We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $289B
1-Year Est. Return 60.46%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
-4.62%
1 Year Est. Return
+60.46%
3 Year Est. Return
+148.24%
5 Year Est. Return
+163.86%
10 Year Est. Return
+570.16%
AUM
$74.4B
AUM Growth
+$4.15B
Cap. Flow
+$8.44B
Cap. Flow %
11.35%
Top 10 Hldgs %
19.16%
Holding
4,480
New
238
Increased
1,135
Reduced
2,408
Closed
335

Sector Composition

Rank Sector Weight
1 Technology 12.15%
2 Consumer Discretionary 6.92%
3 Financials 5.66%
4 Healthcare 5.15%
5 Industrials 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KALV
3501
DELISTED
KalVista Pharmaceuticals
KALV
$26.1K ﹤0.01%
1,769
-3,003
-63% -$43.1K
MFIN icon
3502
Medallion Financial
MFIN
$262M
$26.1K ﹤0.01%
3,066
+2,914
+1,917% +$22.5K
AAWW
3503
CALL
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$25.9K ﹤0.01%
+3
New +$246
IMUX icon
3504
Immunic
IMUX
$226M
$25.8K ﹤0.01%
229
-493
-68% -$57.1K
VBIV
3505
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$25.6K ﹤0.01%
515
-791
-61% -$39.1K
XT icon
3506
iShares Future Exponential Technologies ETF
XT
$4.01B
$25.2K ﹤0.01%
427
-165
-28% -$9.7K
TLK icon
3507
Telkom Indonesia
TLK
$14.5B
$25K ﹤0.01%
784
+428
+120% +$13K
EIGR
3508
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$25K ﹤0.01%
101
-443
-81% -$70K
ATOM icon
3509
Atomera
ATOM
$212M
$25K ﹤0.01%
1,916
-2,576
-57% -$38.6K
STIM icon
3510
Neuronetics
STIM
$211M
$25K ﹤0.01%
8,248
-102
-1% -$345
CTXR icon
3511
Citius Pharmaceuticals
CTXR
$20.1M
$24.8K ﹤0.01%
554
-1,223
-69% -$48.3K
MIST icon
3512
Milestone Pharmaceuticals
MIST
$133M
$24.7K ﹤0.01%
+3,848
New +$24K
TY icon
3513
TRI-Continental Corp
TY
$1.92B
$24.7K ﹤0.01%
+800
New +$24.8K
KVHI icon
3514
KVH Industries
KVHI
$143M
$24.6K ﹤0.01%
2,705
-3,995
-60% -$35.7K
CP icon
3515
Canadian Pacific Kansas City
CP
$82.6B
$24.5K ﹤0.01%
297
-14,190
-98% -$1.07M
CURO
3516
DELISTED
CURO Group Holdings Corp.
CURO
$24.4K ﹤0.01%
1,869
-2,483
-57% -$34.2K
NVEC icon
3517
NVE Corp
NVEC
$563M
$23.3K ﹤0.01%
427
-640
-60% -$37.8K
CHIQ icon
3518
Global X MSCI China Consumer Discretionary ETF
CHIQ
$120M
$23.1K ﹤0.01%
1,166
-680
-37% -$15.5K
MRUS
3519
DELISTED
Merus
MRUS
$23.1K ﹤0.01%
873
+854
+4,495% +$22.9K
ABUS icon
3520
Arbutus Biopharma
ABUS
$906M
$23.1K ﹤0.01%
7,743
-17,113
-69% -$52.4K
GRTS
3521
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$22.9K ﹤0.01%
5,551
-11,446
-67% -$60.6K
USLM icon
3522
United States Lime & Minerals
USLM
$3.37B
$22.5K ﹤0.01%
970
-1,315
-58% -$31.7K
WIP icon
3523
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$474M
$22.5K ﹤0.01%
416
DS
3524
DELISTED
Drive Shack Inc.
DS
$22.4K ﹤0.01%
14,570
-28,409
-66% -$38.6K
TEF
3525
DELISTED
Telefonica
TEF
$22.2K ﹤0.01%
4,768
-12,539
-72% -$55.8K

Similar funds

BNP Paribas Financial Markets's Q1 2022 Portfolio in Review

As of Q1 2022, BNP Paribas Financial Markets held 4,480 positions worth $74.4B, up 5.9% from $70.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

BNP Paribas Financial Markets deployed $8.44B of net new capital in Q1 2022, opening 238 new positions and adding to 1,135 existing holdings. Its largest new stake was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $283M trimmed.

  • BNP Paribas Financial Markets's largest Q1 2022 buy was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
  • BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2022, an estimated $2.42B increase.
  • BNP Paribas Financial Markets's biggest Q1 2022 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $283M.
  • BNP Paribas Financial Markets fully exited Xilinx Inc in Q1 2022, selling an estimated $301M.
  • BNP Paribas Financial Markets's ten largest holdings make up 19% of its $74.4B portfolio in Q1 2022.
  • BNP Paribas Financial Markets opened 238 new positions and closed 335 in Q1 2022.
  • BNP Paribas Financial Markets's portfolio value rose 5.9% quarter-over-quarter to $74.4B.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2022, filed 17 May 2022.